KalVista Pharmaceuticals, Inc.
KALV
$13.05
-$0.26-1.95%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.86% | 234.99% | 31.60% | 41.39% | 40.85% |
| Total Receivables | 39.28% | -60.30% | -39.30% | -40.24% | -41.69% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 34.27% | -1.68% | -13.83% | -15.73% | 2.58% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 7.09% | 156.82% | 18.40% | 27.89% | 30.97% |
|
|
|||||
| Total Current Assets | 7.09% | 156.82% | 18.40% | 27.89% | 30.97% |
| Net Property, Plant & Equipment | -17.66% | -23.46% | -19.37% | -23.35% | -15.07% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 173.02% | 249.37% | 96.44% | 470.75% | 434.91% |
| Total Assets | 6.53% | 142.17% | 15.92% | 24.86% | 28.49% |
|
|
|||||
| Total Accounts Payable | -46.38% | 88.84% | 6.17% | 113.28% | 89.06% |
| Total Accrued Expenses | 120.25% | 23.42% | 31.79% | 30.25% | 35.82% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 51.84% | 21.65% | 33.89% | 12.66% | 19.78% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 98.04% | 33.91% | 24.86% | 58.58% | 51.72% |
|
|
|||||
| Total Current Liabilities | 98.04% | 33.91% | 24.86% | 58.58% | 51.72% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -28.01% | -30.67% | -28.58% | -27.34% | -15.82% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 439.10% | 415.53% | 10.46% | 30.49% | 29.96% |
|
|
|||||
| Common Stock & APIC | 10.88% | 44.75% | 34.08% | 34.31% | 34.04% |
| Retained Earnings | -39.05% | -41.37% | -39.49% | -38.48% | -36.91% |
| Treasury Stock & Other | -49.48% | 32.97% | 22.05% | 0.76% | -13.99% |
| Total Common Equity | -53.82% | 63.83% | 17.08% | 24.02% | 28.29% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -53.82% | 63.83% | 17.08% | 24.02% | 28.29% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -53.82% | 63.83% | 17.08% | 24.02% | 28.29% |
|
|
|||||